Altimmune Inc (NASDAQ:ALT)

0.5085
Delayed Data
As of 4:00pm ET
 +0.0635 / +14.27%
Today’s Change
0.41
Today|||52-Week Range
4.75
-74.45%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues10.2M10.6M5.2M10.7M
 
 
 
 
 
Depreciation And Amortization150.0K141.6K143.4K139.0K
 
 
 
 
 
 
Operating ExpensesGross Income10.0M------
 
 
General Expenses20.2M11.4M16.4M25.2M
 
 
 
 
 
Research And Development9.3M5.1M4.8M18.4M
 
 
 
 
 
Total Operating Expenses20.4M11.5M16.5M25.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-10.2M-856.6K-11.3M-14.6M
 
 
 
 
 
Extraordinary Credit508.8K299.5K217.1M90.4K
 
 
 
 
 
Extraordinary Charge---2.5M-957.1K-37.4M
 
 
 
 
Interest Expense On Debt211.1K54.6K--162.1K
 
 
 
 
Other Expenses-760.00-221.1K7.9K5.7K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-9.9M-3.4M205.0M-52.1M
 
 
 
 
 
Income Taxes-61.7K-61.7K-11.2M-5.6M
 
 
 
 
 
Preferred Dividend0.000.000.00-4.9M
 
 
Net Income-10.0M-3.4M193.9M-46.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS5.8M6.4M--12.8M
 
 
 
 
Shares To Calculate EPS Diluted5.8M6.4M--12.8M
 
 
 
 
 
Earnings Per ShareEPS-$1.70-$0.50---$4.01
 
 
 
 
EPS Diluted-$1.70-$0.50---$4.01